MyAverix Finance
SHE · Healthcare
Tibet Duo Rui Pharmaceutical Co.Ltd. (301075)
Drug Manufacturers - Specialty & Generic
Tibet Duo Rui Pharmaceutical Co.Ltd. (301075) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $5.28B, P/E ratio is 18.00, net margin is -70.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 301075
Tibet Duo Rui Pharmaceutical Co.Ltd. (301075) — FAQ
What is Tibet Duo Rui Pharmaceutical Co.Ltd.'s market cap?
Tibet Duo Rui Pharmaceutical Co.Ltd. (301075) has a reported market cap of $5.28B (data as of 2026-03-28).
What is 301075's P/E ratio?
The price-to-earnings (P/E) ratio for Tibet Duo Rui Pharmaceutical Co.Ltd. (301075) is 18.00 (data as of 2026-03-28).
Does Tibet Duo Rui Pharmaceutical Co.Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Tibet Duo Rui Pharmaceutical Co.Ltd. (301075). Check the MyAverix Finance app for the latest dividend data.
What sector is Tibet Duo Rui Pharmaceutical Co.Ltd. in?
Tibet Duo Rui Pharmaceutical Co.Ltd. (301075) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 301075 listed on?
301075 is listed on SHE.
What is Tibet Duo Rui Pharmaceutical Co.Ltd.'s net margin?
Tibet Duo Rui Pharmaceutical Co.Ltd. (301075) reports a net margin of -70.8% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.